<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930004</url>
  </required_header>
  <id_info>
    <org_study_id>HU-UFSC 2018</org_study_id>
    <nct_id>NCT03930004</nct_id>
  </id_info>
  <brief_title>Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes</brief_title>
  <official_title>Preclinical Cardiomyopathy in Type 1 Diabetes: Correlation With Autonomic Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roberto Léo da Silva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Cardiologia de Santa Catarina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 1 diabetes mellitus is a chronic autoimmune disease, associated with an increased risk
      of cardiovascular diseases. The development of cardiomyopathy in type 1 diabetes, independent
      of hypertension and coronary heart disease, is still controversial. A possible mechanism for
      diabetic cardiomyopathy is autonomic dysfunction. This study aims to evaluate cardiac
      function and structure, and to relate them with autonomic dysfunction in type 1 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 6, 2018</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Preclinical myocardial dysfunction</measure>
    <time_frame>At patient inclusion.</time_frame>
    <description>Incidence of patients with alteration in left ventricular myocardial strain (≤ 17% in absolute value).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular diastolic dysfunction</measure>
    <time_frame>At patient inclusion.</time_frame>
    <description>Incidence of patients with signs of diastolic dysfunction: average E/e' ratio (abnormal when &gt; 14)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular hypertrophy</measure>
    <time_frame>At patient inclusion.</time_frame>
    <description>Incidence of patients with LV mass by linear measurements &gt; 95 g/m2 if women and &gt; 115 g/m2 if men.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left atrial dysfunction</measure>
    <time_frame>At patient inclusion.</time_frame>
    <description>Incidence of patients with abnormal reservoir strain (normal range: 38%-41%), or abnormal conduit strain (normal range: 21%-25%), or abnormal contractile strain (normal range: 16%-19%).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetic Cardiomyopathies</condition>
  <condition>Autonomic Neuropathy, Diabetic</condition>
  <arm_group>
    <arm_group_label>Type 1 diabetic patients</arm_group_label>
    <description>Patients diagnosed with type 1 diabetes mellitus with criteria for cardiovascular autonomic neuropathy, asymptomatic, normotensive, with negative medical history of cardiovascular disease.
Transthoracic echocardiography, including: tissue Doppler indices of diastolic filling and speckle tracking for systolic and diastolic strain/strain rate, exclusion of valvular abnormalities, assessment of heart structure and function.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control - Healthy subjects</arm_group_label>
    <description>Fifteen age- and sex-matched healthy control subjects, asymptomatic, normotensive, with negative medical history of cardiovascular disease.
Transthoracic echocardiography, including: tissue Doppler indices of diastolic filling and speckle tracking for systolic and diastolic strain/strain rate, exclusion of valvular abnormalities, assessment of heart structure and function.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Selection of patients from a tertiary hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type 1 diabetes mellitus

        Exclusion Criteria:

          -  hypertension

          -  coronary artery disease

          -  heart valve disease

          -  ventricular dysfunction

          -  radiotherapy or chemotherapy

          -  alcoholism

          -  limited acoustic window
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thais R Weber, MD</last_name>
    <role>Study Chair</role>
    <affiliation>HU/UFSC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HU/UFSC</name>
      <address>
        <city>Florianopolis</city>
        <state>SC</state>
        <zip>88036-500</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>February 14, 2019</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>October 6, 2019</last_update_submitted>
  <last_update_submitted_qc>October 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Cardiologia de Santa Catarina</investigator_affiliation>
    <investigator_full_name>Roberto Léo da Silva</investigator_full_name>
    <investigator_title>Clinical Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Neuropathies</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Diabetic Cardiomyopathies</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

